CPHRFCipher Pharmaceuticals, Inc.

About Cipher Pharmaceuticals, Inc. (CPHRF)

Cipher Pharmaceuticals, Inc. (CPHRF) is a Drug Manufacturers - Specialty & Generic company headquartered in Mississauga, ON, Canada whose shares trade over-the-counter on the OTCQX tier.

Cipher Pharmaceuticals Inc. ("Cipher") is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. Cipher operates a lean corporate structure, employs strategic operational partnerships, out and in-licenses products, in addition to making selective investments in drug development to assemble a broad portfolio of prescription products.

Products and services

Cipher's products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products, among others.

CPHRF key facts

Ticker symbol

CPHRF

Market tier

OTCQX

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Mississauga, ON, Canada

Country of incorporation

CA

Year of incorporation

2004

Employees

62

Estimated market cap

$211.51M (as of Apr 9, 2025)

Shares outstanding

25,622,529

Reporting standard

International Reporting: Toronto Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Interim Financial Report (Sep 30, 2024)

Cipher Pharmaceuticals, Inc. leadership

• Craig Mull — Interim CEO
• Bryan Jacobs — President
• Ryan Mailling — CFO, Company Secretary
• Hamed Ghanei — CBO
• Accounts Payable — Other

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQX stocks · OTC stocks starting with C